Max India Limited operates in the Hospital and medical service plans sector. Max India Limited (Max India) is a manufacturer of speciality plastic film products for packaging industry. The Company is in the business of clinical research through its wholly owned subsidiary Max Neeman Medical International Limited (MNMI). MNMI is a clinical research organization (CRO) that provides a range of clinical research services to global pharmaceutical, device and biotechnology companies. The Company operates in seven business segments: speciality plastic products, life insurance, healthcare business, clinical research, business investments, health insurance and others. Speciality plastic products include polymers of propylene, leather finishing transfer foils and related products. Clinical research includes business activities, such as project management services, data base management services, monitoring services and clinical trial pharmacy supply chain management services to the pharmaceutical, medical device, biotechnology and contact research organizations worldwide. In
our complete report available for purchase the company is compared to: ABB Limited, Kesoram Industries Limited and Bombay Burmah Trading Corporation Limited.